Spondyloarthritis Archives - PharmaDeviceNews

Akeso’s gumokimab advances to NMPA review in ankylosing spondylitis: Is China’s IL-17 race entering a new phase?

by Pallavi Madhiraju
January 19, 2026
0 Comments

Akeso’s gumokimab enters NMPA review for ankylosing spondylitis after Phase 3 success. Find out what this could mean for IL-17 therapies in China.

Can a global trials map help fix spondyloarthritis’s fragmented development landscape?

Explore what global spondyloarthritis trial trends in 2025 reveal about innovation gaps, sponsor risk, and regulatory hurdles. Read the full industry analysis.